UNICA IRIS Institutional Research Information System

MASSA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 138.234
NA - Nord America 9.103
AS - Asia 1.451
SA - Sud America 22
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 148.833
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 135.786
US - Stati Uniti d'America 9.047
CN - Cina 1.002
UA - Ucraina 953
SE - Svezia 581
SG - Singapore 291
FI - Finlandia 245
GB - Regno Unito 238
DE - Germania 221
FR - Francia 75
CA - Canada 50
KR - Corea 47
IN - India 34
NL - Olanda 25
BE - Belgio 21
IR - Iran 21
IE - Irlanda 15
AT - Austria 13
RU - Federazione Russa 13
VN - Vietnam 12
BR - Brasile 11
CZ - Repubblica Ceca 11
ES - Italia 10
HK - Hong Kong 10
EU - Europa 7
TW - Taiwan 7
PH - Filippine 6
JP - Giappone 5
MX - Messico 5
RO - Romania 5
TR - Turchia 5
AU - Australia 4
AR - Argentina 3
DK - Danimarca 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PL - Polonia 3
UG - Uganda 3
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
ID - Indonesia 2
PE - Perù 2
PT - Portogallo 2
AM - Armenia 1
CI - Costa d'Avorio 1
CO - Colombia 1
EC - Ecuador 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 148.833
Salva come PNG Salva come JPEG
Città #
Cagliari 130.985
Uta 4.183
Fairfield 1.169
Woodbridge 1.022
Houston 822
Chandler 671
Ashburn 582
Jacksonville 555
Boardman 552
Seattle 495
Wilmington 482
Ann Arbor 480
Nyköping 463
Cambridge 413
Dearborn 257
Nanjing 171
Singapore 168
Santa Clara 132
Boston 131
Beijing 129
Shanghai 115
Helsinki 100
New York 95
San Diego 91
Guangzhou 76
Milan 63
Nanchang 56
Shenyang 45
Hebei 42
Seoul 38
Redwood City 36
Changsha 35
Jiaxing 33
London 33
Toronto 33
Verona 32
Los Angeles 29
Norwalk 28
Rome 28
Tianjin 27
Jinan 26
Orange 26
Auburn Hills 19
Brussels 19
Pune 19
Mountain View 18
Hangzhou 17
Kunming 17
Zhengzhou 16
Dublin 15
Munich 15
Wuhan 15
Hefei 14
Sassari 14
San Mateo 13
Amsterdam 12
Dong Ket 12
Ningbo 12
Vienna 11
Kilburn 10
Taizhou 10
Augusta 8
Berlin 8
Kyjov 8
Rio de Janeiro 8
Hong Kong 7
Hounslow 7
Naples 7
Salerno 7
Torino 7
Turin 7
Atlanta 6
Chicago 6
Frankfurt am Main 6
Leawood 6
Nuremberg 6
Paris 6
Phoenix 6
Redmond 6
Saint Petersburg 6
San Sperate 6
Shenzhen 6
Washington 6
Barcelona 5
Borås 5
Brandizzo 5
Monmouth Junction 5
Xian 5
Florence 4
Halle 4
Indiana 4
Mexico City 4
Millbury 4
Quartu Sant'Elena 4
Rockville 4
San Francisco 4
Sheffield 4
Somma Vesuviana 4
Taipei 4
Amman 3
Totale 145.445
Salva come PNG Salva come JPEG
Nome #
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.793
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.897
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.870
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.762
Molecular-biology-driven treatment for metastatic colorectal cancer 2.666
Sense of coherence and physical health-related quality of life in Italian chronic patients: The mediating role of the mental component 2.592
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.530
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.495
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 2.449
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.353
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.255
Health related quality of life in patients with onco-hematological diseases 2.117
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.113
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial 1.795
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.792
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial 1.716
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.701
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 1.683
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.677
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.644
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.618
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.608
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.604
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 1.577
The Quality of Life of People with Solid Cancer is Less Worse than Other Diseases with better Prognosis, Except in the Presence of Depression 1.544
Weight loss in cancer patients: a plea for a better awareness of the issue 1.534
Case-control Phase ii clinical trial to assess efficacy and safety, of the same antineoplastic treatment(s) in elderly "fit" compared to adult patients with cancer at different sites 1.502
null 1.489
Immunotherapy and Cancer: The Multi-Omics Perspective 1.484
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause 1.459
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.450
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.431
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia = Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: Final analysis of GIDEON study in Italy 1.422
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.419
null 1.306
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.254
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.228
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens 1.163
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.116
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.086
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.075
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 1.012
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 977
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 946
null 944
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 922
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 917
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature 908
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 896
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 893
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 887
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 856
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 852
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 807
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 771
null 768
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 747
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 741
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 733
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 724
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 723
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 721
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 719
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 710
null 709
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 708
null 694
null 688
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 687
ALCOL E TUMORE ALLA MAMMELLA 682
null 681
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 662
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy 662
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 650
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 649
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 638
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 622
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 593
Managing cancer-related anorexia/cachexia 582
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 579
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 576
null 572
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 568
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 567
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 563
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer 548
Risk factors for sentinel lymph node involvement in patients with apparent early-stage endometrial cancer: a retrospective single-center study 546
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 539
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 535
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 530
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review 526
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 517
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 512
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 509
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 505
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 504
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 502
Early strain rate impairment during epirubicin treatment correlates with markers of inflammation and oxidative stress 497
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 487
Early contractility impairment during anthracycline treatment revealed by serial tissue Doppler echocardiography in presence of negative biochemical markers 487
Totale 116.519
Salva come PNG Salva come JPEG
Categoria #
all - tutte 200.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.268 0 0 0 0 0 0 3.205 945 608 518 522 1.470
2020/202135.147 1.139 1.216 1.389 7.968 7.397 4.884 3.622 2.503 803 1.576 1.532 1.118
2021/20226.518 644 561 269 475 662 449 288 343 559 485 799 984
2022/202311.849 924 1.351 1.185 1.022 1.030 1.199 557 1.425 815 760 995 586
2023/202415.719 1.349 536 509 1.002 1.561 3.159 1.558 1.010 778 1.337 1.500 1.420
2024/202530.341 7.159 9.174 4.097 3.909 2.022 3.749 231 0 0 0 0 0
Totale 149.179